1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunityActive, not recruitingPhase 32026-04-08NCT06076642